Article Tools

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

Published: May 21, 2013; 08:31 · (Vindobona)

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S. / Picture: © Vindobona Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.

Company Information

Wien (euro adhoc) - Vienna (Austria), May 21, 2013 - Intercell AG (VSE; "ICLL")
announced today that the pediatric indication for IXIARO®, a vaccine to protect
against Japanese Encephalitis (JE), was…

This article includes a total of 623 words.

or Log In